Hyporesponsiveness following booster immunization with bacterial polysaccharides is caused by apoptosis of memory B cells.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Journal of Infectious Diseases

• Publication date

  2012-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/infdis/jir750PMID 22158565
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hyporesponsiveness and its clinical implications after vaccination with polysaccharide or glycoconjugate vaccines

  2011cited by this paper
• B cell repertoire and ageing.

  2010cited by this paper
• Serotype-specific hyporesponsiveness to pneumococcal conjugate vaccine in infants carrying pneumococcus at the time of vaccination.

  2010cited by this paper
• Nasopharyngeal carriage of Streptococcus pneumoniae shortly before vaccination with a pneumococcal conjugate vaccine causes serotype-specific hyporesponsiveness in early infancy.

  2010cited by this paper
• Meningitis in Chad, Niger and Nigeria: 2009 epidemic season.

  2010cited by this paper
• Prevention of meningococcal disease: current use of polysaccharide and conjugate vaccines.

  2010cited by this paper
• Hyporesponsiveness to re-challenge dose following pneumococcal polysaccharide vaccine at 12 months of age, a randomized controlled trial.

  2010cited by this paper
• Maintaining protection against invasive bacteria with protein–polysaccharide conjugate vaccines

  2009cited by this paper
• APRIL is critical for plasmablast survival in the bone marrow and poorly expressed by early-life bone marrow stromal cells.

  2008cited by this paper
• Recommendations of the Advisory Committee on Immunization Practices (ACIP)

  2008cited by this paper
• Neonatal immune response and serum bactericidal activity induced by a meningococcal conjugate vaccine is enhanced by LT-K63 and CpG2006.

  2008cited by this paper
• CpG Drives Human Transitional B Cells to Terminal Differentiation and Production of Natural Antibodies

  2008cited by this paper
• Reconsideration of the Use of Meningococcal Polysaccharide Vaccine

  2007cited by this paper
• Epidemic meningitis, meningococcaemia, and Neisseria meningitidis.

  2007cited by this paper
• Immunogenicity of varying dosages of 7-valent pneumococcal polysaccharide-protein conjugate vaccine in seniors previously vaccinated with 23-valent pneumococcal polysaccharide vaccine.

  2007cited by this paper
• Priming for Immunologic Memory in Adults by Meningococcal Group C Conjugate Vaccination

  2006cited by this paper
• Prevention and control of meningococcal disease. Recommendations of the Advisory Committee on Immunization Practices (ACIP).

  2005cited by this paper
• Effects of Prior Polysaccharide Vaccination on Magnitude, Duration, and Quality of Immune Responses to and Safety Profile of a Meningococcal Serogroup C Tetanus Toxoid Conjugate Vaccination in Adults

  2004cited by this paper
• Immunologic Hyporesponsiveness to Serogroup C but Not Serogroup A following Repeated Meningococcal A/C Polysaccharide Vaccination in Saudi Arabia

  2004cited by this paper
• Revaccination with the 23-valent pneumococcal polysaccharide vaccine in middle-aged and elderly persons previously treated for pneumonia.

  2003cited by this paper
• Vaccination strategies. An overview.

  2003cited by this paper
• Influence of prior meningococcal C polysaccharide vaccination on the response and generation of memory after meningococcal C conjugate vaccination in young children.

  2001cited by this paper
• Comparison of antibody kinetics following meningococcal serogroup C conjugate vaccine between healthy adults previously vaccinated with meningococcal A/C polysaccharide vaccine and vaccine-naïve controls.

  2001cited by this paper
• Immunologic memory 5 years after meningococcal A/C conjugate vaccination in infancy.

  2001influential reference
• Reduced antibody response to revaccination with meningococcal serogroup A polysaccharide vaccine in adults.

  2000cited by this paper
• Can meningococcal C conjugate vaccine overcome immune hyporesponsiveness induced by previous administration of plain polysaccharide vaccine?

  2000cited by this paper
• Meningococcal C polysaccharide vaccine induces immunologic hyporesponsiveness in adults that is overcome by meningococcal C conjugate vaccine.

  2000cited by this paper
• Dietary fiber and weight gain.

  2000cited by this paper
• Immunogenicity and reactogenicity of a group C meningococcal conjugate vaccine compared with a group A+C meningococcal polysaccharide vaccine in adolescents in a randomised observer-blind controlled trial.

  2000cited by this paper
• Dietary fiber and weight gain.

  2000cited by this paper
• Safety of revaccination with pneumococcal polysaccharide vaccine.

  1999cited by this paper
• Immune response to revaccination with meningococcal A and C polysaccharides in Gambian children following repeated immunisation during early childhood.

  1999cited by this paper
• CpG oligodeoxynucleotides can circumvent the Th2 polarization of neonatal responses to vaccines but may fail to fully redirect Th2 responses established by neonatal priming.

  1999cited by this paper
• Induction of immunologic memory by conjugated vs plain meningococcal C polysaccharide vaccine in toddlers: a randomized controlled trial.

  1998cited by this paper
• Induction of immunologic refractoriness in adults by meningococcal C polysaccharide vaccination.

  1998cited by this paper
• Induction of immunologic memory in Gambian children by vaccination in infancy with a group A plus group C meningococcal polysaccharide-protein conjugate vaccine.

  1997cited by this paper
• Clinical evaluation of group A and group C meningococcal polysaccharide vaccines in infants.

  1975cited by this paper

• B cell-expressed CD1d promotes MPL/TDCM lipid emulsion adjuvant effects in polysaccharide vaccines.

  2025cites this paper
• Minimal interval for the administration of a pneumococcal polysaccharide vaccine following the administration of a pneumococcal conjugate vaccine.

  2024cites this paper
• Fasciola hepatica infection modifies IgG1 specific immune response to foot-and-mouse disease virus induced by vaccination.

  2024cites this paper
• Glycoconjugate vaccines against antimicrobial resistant pathogens

  2023cites this paper
• The role of antigen availability during B cell induction and its effect on sustained memory and antibody production after infection and vaccination - Lessons learned from the SARS-CoV-2 pandemic.

  2022cites this paper
• Glycolipid-Containing Nanoparticle Vaccine Engages Invariant NKT Cells to Enhance Humoral Protection against Systemic Bacterial Infection but Abrogates T-Independent Vaccine Responses

  2021cites this paper
• A Nonfunctional Opsonic Antibody Response Frequently Occurs after Pneumococcal Pneumonia and Is Associated with Invasive Disease

  2020cites this paper
• Streptococcus pneumoniae infections before and after the introduction of a conjugated pneumococcal vaccine

  2020cites this paper
• Enfermedad meningocócica: epidemiología, diagnóstico y vacunación

  2020cites this paper
• Corrected and Republished from: A Nonfunctional Opsonic Antibody Response Frequently Occurs after Pneumococcal Pneumonia and Is Associated with Invasive Disease

  2020cites this paper
• B Cell Subsets Differentially Contribute to the T Cell–Independent Memory Pool

  2020cites this paper
• Perioperative Immunization for Splenectomy and the Surgeon's Responsibility: A Review.

  2020cites this paper
• Short Vi-polysaccharide abrogates T-independent immune response and hyporesponsiveness elicited by long Vi-CRM197 conjugate vaccine

  2020cites this paper
• [Alterations in responses to vaccines in older people].

  2019cites this paper
• Immunogenic Responses of Effective Vaccine Candidates against Streptococcus agalactiae in Ruminants

  2019cites this paper
• Immunogenicity of meningococcal polysaccharide ACWY vaccine in primary immunized or revaccinated adults

  2018cites this paper
• Saccharum Alhagi polysaccharide-1 and -2 promote the immunocompetence of RAW264.7 macrophages in vitro.

  2018cites this paper
• Cost-effectiveness analysis of 13-valent pneumococcal conjugate vaccine versus 23-valent pneumococcal polysaccharide vaccine in an adult population in South Korea

  2018cites this paper
• An Adjuvant That Increases Protective Antibody Responses to Polysaccharide Antigens and Enables Recall Responses

  2018cites this paper
• Serotypes With Low Invasive Potential Are Associated With an Impaired Antibody Response in Invasive Pneumococcal Disease

  2018cites this paper
• Glycoconjugate vaccines: Principles and mechanisms

  2018cites this paper
• HIV-related pneumococcal disease prevention in adults

  2017cites this paper
• High-dimensional assessment of B-cell responses to quadrivalent meningococcal conjugate and plain polysaccharide vaccine

  2017cites this paper
• Novel Vi conjugate vaccines against typhoid

  2017influential citation
• No long-term evidence of hyporesponsiveness after use of pneumococcal conjugate vaccine in children previously immunized with pneumococcal polysaccharide vaccine.

  2016cites this paper
• Basic Vaccine Immunology

  2016cites this paper
• No long-term evidence of hyporesponsiveness following the use of pneumococcal conjugate vaccine in children previously immunised with pneumococcal polysaccharide vaccine

  2016cites this paper
• The Anatomy of Immunity

  2015cites this paper
• The Generation of immunological memory in early murine life. Pneumococcal conjugate vaccination with novel adjuvants by different immunization routes

  2014cites this paper
• Pneumococcal vaccination: what have we learnt so far and what can we expect in the future?

  2014cites this paper
• Sequential administration of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine-naïve adults 60-64 years of age.

  2014cites this paper
• Impaired serotype-specific immune function following pneumococcal vaccination in infants with prior carriage.

  2014cites this paper
• Decreased immune response to pneumococcal conjugate vaccine after 23-valent pneumococcal polysaccharide vaccine in children.

  2014cites this paper
• Review: current and new generation pneumococcal vaccines.

  2014cites this paper
• Impaired immune function following pneumococcal vaccination in infants with prior carriage

  2014cites this paper
• Polysaccharide-specific B cell responses to vaccination in humans

  2014cites this paper
• 2 – Vaccine immunology

  2013cites this paper
• Influence of initial vaccination with 13-valent pneumococcal conjugate vaccine or 23-valent pneumococcal polysaccharide vaccine on anti-pneumococcal responses following subsequent pneumococcal vaccination in adults 50 years and older.

  2013cites this paper
• Bacterial polysaccharide-mediated downregulation of TACI and B-cell apoptosis contribute to the hyporesponsiveness against bacterial polysaccharides vaccines.

  2013cites this paper
• Glycoconjugate vaccines

  2013influential citation
• Comparação de resposta à vacinação com três esquemas diferentes de vacina antipneumocócica em indivíduos infectados por vírus de imunodeficiência humana

  2013cites this paper
• Enfermedad meningocócica: epidemiología, diagnóstico y vacunación Meningococcal disease: epidemiology, diagnosis and vaccination

  2013cites this paper
• Pneumococcal Polysaccharide Abrogates Conjugate-Induced Germinal Center Reaction and Depletes Antibody Secreting Cell Pool, Causing Hyporesponsiveness

  2013cites this paper
• Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in adults 70 years of age and older previously vaccinated with 23-valent pneumococcal polysaccharide vaccine.

  2013cites this paper
• Pneumococcal Conjugate Vaccine for Adults: A New Paradigm

  2012cites this paper